3 Funds To Gain From Antiviral Drug Therapies

Fidelity Advisor Biotechnology Fund Class A (FBTAX - Free Report) aims for capital appreciation. The fund invests the majority of its assets in securities of companies that are engaged in the research, development, manufacture, and distribution of several biotechnological products and services, etc. These companies are well positioned to benefit considerably from scientific and technological advances in biotechnology.FBTAX is a non-diversified fund.  AbbVie Incis among FBTAX’s top holdings. FBTAX carries a Zacks Mutual Fund Rank #2.

This Zacks Sector – Health has a history of positive total returns for more than 10 years.

FBTAX has an annual expense ratio of 1.04%, which is below the category average of 1.24%. It has returned 5.6% over the past three years. The fund has no minimum initial investment.

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.